vol. 57 March 2025

KOBE Biomedical Innovation Cluster newsletter vol. 57
- March 2025 -

vol. 57 March 2025

Hello,

Our new business year will start in April and we have been busy preparing for new year's activities. We will participate in Medical Fair Thailand which will be held in September 2025 in Bangkok and we have started recruiting 5 co-exhibitors. Last week we organized Thai Seminar.

Thai Seminar
Companies interested in Thai market and the co-exhibition itself participated in the seminar and participants listened to the main lectures "How to be Successful in MedTech Business in Thai" and "Thai Medical Device Regulations" intensively to gain insights to their business. We hope that many companies will apply for the co-exhibition and we are looking forward to supporting them!

If you missed our past issues of KBIC newsletter, please visit Newsletter Archive.

FBRI Editorial Team

NEWS

Aeras Bio and RD Dental Clinic started Japan’s First Clinical Study on "Pulp Regeneration Treatment" Using Allogeneic Dental Pulp Stem Cells

Dental Clinic Aims to Expand the Scope of Pulp Regeneration Treatment to More Patients
Medical Corporation Kenkō Mirai RD Dental Clinic

Key Points
RD Dental Clinic (Director: Misako Nakashima, Location: Kobe City, Hyogo Prefecture), part of the Medical Corporation Kenkō Mirai, began recruiting patients for a clinical study evaluating the safety of pulp regeneration treatment using allogeneic dental pulp stem cells, the first of its kind in Japan, on January 28, 2025.
In the "Autologous Dental Pulp Regeneration Treatment" introduced in 2020, tooth extraction (such as from baby teeth or wisdom teeth) was required for stem cell collection. However, the results of this clinical study could potentially allow patients without such teeth to receive pulp regeneration treatment.

Medicaroid Files for CE Mark Certification Under MDR for the hinotori™ Surgical Robot System

Medicaroid Corporation (HQ: Kobe, Japan; Board Director, CEO and President Koji Muneto, hereinafter referred to as "Medicaroid") announced that an application for hinotori™ Surgical Robot System as a CE-marked product under the Medical Device Regulation (MDR (2017/745)) has been filed.
An immediate announcement will be made once the approval of the hinotori™ is obtained